China's insurance industry chalked up total premium income of around CNY6.12tn ($882bn), up by 7.4% year on year, driven by the life market, according to data released by the National Financial Regulatory Administration (NFRA).
Life insurance companies reported a combined CNY4.36tn ($629bn) in premium income in 2025, up by 8.9% over 2024, due to strong demand for savings.
Fifty-seven (57) unlisted life insurers have reported a combined net profit of CNY66.62bn ($9.60bn) for the financial year ended 31 December 2025, representing a surge of 167.7% over 2024, according to the insurers' unaudited 4Q2025 solvency reports.
Hong Kong and Shanghai-listed China Life Insurance Company (China Life) has announced that it intends to enter into an agreement with China Life Qiyuan by 30 September 2026 to form a partnership to establish or acquire project companies engaged in the senior care real estate business, either directly or through its invested funds.
Nasdaq-listed Pomdoctor, an online medical services platform for chronic diseases in China, has announced a strategic initiative to deepen the integration of its platform with China's national and local coordinated medical insurance systems across major cities nationwide.
The Philippine life insurance industry saw steady growth in 2025, thanks to rising insurance penetration, higher premiums and improving profitability. Data from the Insurance Commission (IC) show that, insurance penetration in the Philippines increased to 1.78% in 2025 from 1.67% in 2024, with insurance density reaching a record high of PHP4,384.56 ($74.54), up from PHP3,894.03 a year earlier.
The Prudential Life Insurance Company (POJ) and its parent company, Prudential Financial, have announced a voluntary 90-day suspension of new sales activity at Prudential of Japan.
Life and pension insurer Turkiye Hayat Emeklilik has chalked up net profits of TRY15.5bn for the financial year ended 31 December 2025, a 67% increase year on year.
Called AIA Voluntary Health Insurance SelectWise Scheme (SelectWise), this is the "first" voluntary health insurance scheme (VHIS) plan in the market to feature a dedicated medical journey.
AIA Group's Board of Directors have appointed Mr Ku Man (also known as Mr David Ku) and Ms Shu Khoo Independent Non-executive Directors, effective 5 February 2026.